<DOC>
	<DOCNO>NCT01379521</DOCNO>
	<brief_summary>This study evaluate role everolimus combination local Transcatheter Arterial Chemoembolization ( TACE ) procedure patient suffer localize unresectable Hepatocellular Carcinoma ( HCC ) .</brief_summary>
	<brief_title>Safety Efficacy RAD001 + TACE Localized Unresectable HCC</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Newly diagnose hepatocellular carcinoma limit liver suitable resection , liver transplant , radiofrequency ablation . Intermediate stage ( stage B ) ( accord recognize guideline ) suitable TACE therapy At least one nodule &gt; 2cm ≤ 15cm diameter vascular invasion abdominal lymph node distant metastasis . Must 1 tumor measure 1 dimension accord specify criterion ( RECIST mRECIST ) previously treat type therapy . ECOG performance status &lt; 2cm Cirrhotic status ChildPugh class A early B HBVDNA HBsAg positive screen baseline : preventative treatment antiviral start 12 week prior receive study drug Any local and/or investigational drug within 28 day prior randomization Active bleeding last 28 day prior screen include variceal bleed Prior therapy mTOR inhibitor Tumor burden &gt; 60 % liver involvement Prior systemic local therapy include TACE except first TACE Day 0 ) , surgery liver transplantation Failed first TACE Day 0 , Cycle 1 reason Known history human immunodeficiency virus ( HIV ) seropositivity ( HIV test mandatory ) Alcohol intake 80 gram per day Undergone major surgery ≤ 3 week prior start study drug recover surgery Female patient pregnant breast feeding , adult reproductive potential use effective birth control methods Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Localised</keyword>
	<keyword>unresectable</keyword>
	<keyword>chemoembolization</keyword>
</DOC>